Sign Up Today and Learn More About Marea Therapeutics Stock
Invest in or calculate the value of your shares in Marea Therapeutics or other pre-IPO companies through EquityZen's platform.
Marea Therapeutics Stock (MART)
Marea is a biotechnology firm that uses the advancements in human genetics next-generation medications for cardiometabolic illnesses.
About Marea Therapeutics Stock
Founded
2022
Headquarters
San Francisco, CA, US
Industries
Science and Engineering, Health Care, Biotechnology
Marea Therapeutics Press Mentions
Stay in the know about the latest news on Marea Therapeutics
Marea Therapeutics Announces Late-Breaking Oral Presentation at the 93rd EAS Congress
businesswire • Apr 15, 2025
Marea Therapeutics Provides Update on Corporate Progress Including Positive Topline Results from Phase 2a Clinical Trial of MAR001 for Cardiovascular Disease and Disclosure
businesswire • Feb 01, 2025
Marea Therapeutics Expands Management Team and Board of Directors
morningstar • Dec 19, 2024
Chutes & Ladders—Third Rock's cardiometabolic biotech unveils C-suite
fiercebiotech • Aug 05, 2024
Marea’s $190m double round heads latest biotech financings
pharmaphorum • Aug 05, 2024
Marea Therapeutics Management
Leadership team at Marea Therapeutics
Board Member
Maha Katabi
Board Member
Antoine Boulanger
Join now and verify your accreditation status to gain access to:
- Marea Therapeutics Current Valuation
- Marea Therapeutics Stock Price
- Marea Therapeutics Management
- Available deals in Marea Therapeutics and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Marea Therapeutics Cap Table and Funding History by Share Class and Liquidity Preferences
- Marea Therapeutics Revenue and Financials
- Marea Therapeutics Highlights
- Marea Therapeutics Business Model
- Marea Therapeutics Risk Factors
- Marea Therapeutics Research Report from SACRA Research
Trading Marea Therapeutics Stock
How to invest in Marea Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Marea Therapeutics through EquityZen funds. These investments are made available by existing Marea Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Marea Therapeutics stock?
Shareholders can sell their Marea Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
